1. Home
  2. CRBU vs EXOZ Comparison

CRBU vs EXOZ Comparison

Compare CRBU & EXOZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • EXOZ
  • Stock Information
  • Founded
  • CRBU 2011
  • EXOZ 2014
  • Country
  • CRBU United States
  • EXOZ United States
  • Employees
  • CRBU N/A
  • EXOZ N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • EXOZ
  • Sector
  • CRBU Health Care
  • EXOZ
  • Exchange
  • CRBU Nasdaq
  • EXOZ NYSE
  • Market Cap
  • CRBU 93.0M
  • EXOZ 89.8M
  • IPO Year
  • CRBU 2021
  • EXOZ N/A
  • Fundamental
  • Price
  • CRBU $1.36
  • EXOZ $9.15
  • Analyst Decision
  • CRBU Strong Buy
  • EXOZ
  • Analyst Count
  • CRBU 4
  • EXOZ 0
  • Target Price
  • CRBU $8.50
  • EXOZ N/A
  • AVG Volume (30 Days)
  • CRBU 1.2M
  • EXOZ 3.2K
  • Earning Date
  • CRBU 08-05-2025
  • EXOZ 08-15-2025
  • Dividend Yield
  • CRBU N/A
  • EXOZ N/A
  • EPS Growth
  • CRBU N/A
  • EXOZ N/A
  • EPS
  • CRBU N/A
  • EXOZ N/A
  • Revenue
  • CRBU $9,918,000.00
  • EXOZ N/A
  • Revenue This Year
  • CRBU $12.83
  • EXOZ N/A
  • Revenue Next Year
  • CRBU N/A
  • EXOZ N/A
  • P/E Ratio
  • CRBU N/A
  • EXOZ N/A
  • Revenue Growth
  • CRBU N/A
  • EXOZ N/A
  • 52 Week Low
  • CRBU $0.66
  • EXOZ $8.50
  • 52 Week High
  • CRBU $3.00
  • EXOZ $23.99
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 62.05
  • EXOZ N/A
  • Support Level
  • CRBU $1.12
  • EXOZ N/A
  • Resistance Level
  • CRBU $1.33
  • EXOZ N/A
  • Average True Range (ATR)
  • CRBU 0.11
  • EXOZ 0.00
  • MACD
  • CRBU 0.00
  • EXOZ 0.00
  • Stochastic Oscillator
  • CRBU 79.49
  • EXOZ 0.00

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About EXOZ EXOZYMES INC

EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.

Share on Social Networks: